An unusual case of adult disseminated cutaneous Langerhans cell histiocytosis

Dermatology Online Journal

Volumn 12, Issue 6, 2006, Pages

  Moravvej, Hamideh ^a   Yousefi, Maryam ^b   Barikbin, Behrooz ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETOPOSIDE; PROTEIN S 100; PSORALEN; STEROID; T6 ANTIGEN; THALIDOMIDE; BIOLOGICAL MARKER; CD1 ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTRON THERAPY; EPIDERMIS; HISTIOCYTE; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAINTENANCE THERAPY; MALE; MONONUCLEAR CELL; NAIL DISEASE; PAPULAR RASH; PHOTOTHERAPY; PUVA; RECURRENT DISEASE; SKIN BIOPSY; SKIN DISEASE; WHOLE BODY RADIATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; ANTIGENS, CD1; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CYCLOSPORINE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NAIL DISEASES; PUVA THERAPY; S100 PROTEINS; SKIN DISEASES; THALIDOMIDE;

EID: 33750964171     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Warren T Goodman, Terry L Barrett. Disorders of Langerhans cells and macrophages, in textbook of Dermatology edited by Jean L Bolognia, Joseph L Jorizzo, Ronald P Rapini.2003;vol.2:1429-1433
2. S.E. Chang, G.J. Koh, J.H. Choi, K.J. Sung, K.C. Moon, J.K. Koh.Widespread skin-limited adult Langerhans cell histiocytosis: Long-term follow-up with good response to interferon alpha. Clin Expl Dermatol 2002; 27:135-137.
3. de Berker, Lever LR, Windebank K. Nail features in Langerhans cell histiocytosis. Br J Dermatol 1994;130:523-7.
4. Stefanato CM, Andersen WK, Calonje E et al. Langerhans cell histiocytosis in the elderly: a report of three cases. J Am Acad Dermatol 1998; 39: 375 8.
5. Munn S & Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 1998; 12: 269 86.
6. Chu AC. The confusing state of the histocytoses. Br J Dermatol 2000; 143: 475 6.
7. Baldo A, Vitiello A, Argenziano G et al. Pure cutaneous relapsing Langerhans cell histiocytosis in an adult. Eur J Dermatol 1998; 8: 501 2.
8. Gerlach B, Stein A, Fischer R et al. Langerhanszell-Histiozytose im Alter. Hautarzt 1998; 49: 23 30.
9. Lair G, Marie I, Cailleux N et al. Histiocytose Langerhansienne de l'adulte: localisations cutanŽomuqueuses rŽgressives apr□s traitment par thalidomide. Rev Med Interne 1998; 19: 196 8.
10. Conias S, Strutton G, Stephenson G. Adult cutaneous Langerhans-cell histiocytosis. Australas J Dermatol 1998; 39: 106 8.
11. Rentsch JL, Martin EM, Harrison LC, Wicks IP. Prolonged response of multicentric reticulohistiocytosis to low dose methotrexate. J Rheumatol 1998; 25: 1012 15.
12. Cash JM, Tyree J, Recht M. Severe multicentric reticulohistiocytosis: disease stabilization achieved with methotrexate and hydroxychloroquine. J Rheumatol 1997; 24: 2250 3.
13. Liang GC & Granston AS. Complete remission of multicentric reticulohistiocytosis with combination therapy of steroid, cyclophosphamide, and low-dose pulse methotrexate. Arthritis Rheum 1996; 39: 375 8.
14. Womer RB, Anunciato KR, Chehrenama M. Oral methotrexate and alternate-day prednisone for low-risk Langerhans cell histiocytosis. Med Paediatr Oncol 1995; 20: 70 3.
15. Steen AE, Steen KH, Bauer R, Bieber T. Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate. Br J Dermatol. 2001 Jul;145(1):137-40.
16. Itoh H, Miyaguni H, Kataoka H, Akiyama Y, Tateyama S, Marutsuka K, Asada Y, Ogata K, Koono M. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman: report of a fatal case. J Cutan Pathol. 2001 Aug;28 (7):371-8.
17. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis; diagnosis, natural history, management, and outcome. Cancer1999; 85: 2278.
18. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006 Mar 17; [Epub ahead of print].
19. Walia SS, Gayer K. An unusual presentation of refractory cutaneous Langerhans cell histiocytosis in an adult. J Drugs Dermatol. 2006 Feb;5(2):174-7.
20. Manfredi M, Corradi D, Vescovi P. Langerhans-cell histiocytosis: a clinical case without bone involvement. J Periodontol. 2005 Jan;76(1):143-7.
21. Gotz G, Fichter J. Langerhans'-cell histiocytosis in 58 adults. Eur J Med Res. 2004 Nov 29;9(11):510-4.
22. Sander CS, Kaatz M, Elsner P. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide. Dermatology. 2004;208(2):149-52.
23. Franks ME, Macpherson GR, Figg WD. Thalidomide. Lancet 2004;363: 1802 1811.
24. Moreira AL, Sampaio EP, Zmuidnas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing m-RNA degradation. J Exp Med 1993;177: 1675 1680.
25. Thomas L, Ducros B, Secchi T, Balme B, Moulin G. Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review. Arch Dermatol 1993;129: 1261 1264.
26. Kolde G, Schulze P, Sterry W. Mixed response to thalidomide in adults: two cases of multisystem Langerhans' cell histiocytosis. Acta Derm Venereol 2002;82: 384 386.
27. Henter JI, Karlen J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans'-cell histiocytosis with etanercept. N Engl J Med 2001;345: 1577 1578.